Farrell B - Search Results

1

Achieving sustainable healthcare through deprescribing.

Gnjidic D, Johansson M, Meng DM, Farrell B, Langford A, Reeve E. Gnjidic D, et al. Among authors: farrell b. Cochrane Database Syst Rev. 2022 Oct 4;10(10):ED000159. doi: 10.1002/14651858.ED000159. Cochrane Database Syst Rev. 2022. PMID: 36194519 Free PMC article. No abstract available.

2

Deprescribing: A narrative review of the evidence and practical recommendations for recognizing opportunities and taking action.

Reeve E, Thompson W, Farrell B. Reeve E, et al. Among authors: farrell b. Eur J Intern Med. 2017 Mar;38:3-11. doi: 10.1016/j.ejim.2016.12.021. Epub 2017 Jan 5. Eur J Intern Med. 2017. PMID: 28063660 Review.

3

Deprescribing versus continuation of chronic proton pump inhibitor use in adults.

Boghossian TA, Rashid FJ, Thompson W, Welch V, Moayyedi P, Rojas-Fernandez C, Pottie K, Farrell B. Boghossian TA, et al. Among authors: farrell b. Cochrane Database Syst Rev. 2017 Mar 16;3(3):CD011969. doi: 10.1002/14651858.CD011969.pub2. Cochrane Database Syst Rev. 2017. PMID: 28301676 Free PMC article. Review.

4

Deprescribing: An educational imperative.

Raman-Wilms L, Farrell B, Sadowski C, Austin Z. Raman-Wilms L, et al. Among authors: farrell b. Res Social Adm Pharm. 2019 Jun;15(6):790-795. doi: 10.1016/j.sapharm.2018.08.011. Epub 2018 Aug 28. Res Social Adm Pharm. 2019. PMID: 30241871

5

Deprescribing guidelines: An international symposium on development, implementation, research and health professional education.

Farrell B, Conklin J, Dolovich L, Irving H, Maclure M, McCarthy L, Moriarty F, Pottie K, Raman-Wilms L, Reeve E, Thompson W. Farrell B, et al. Res Social Adm Pharm. 2019 Jun;15(6):780-789. doi: 10.1016/j.sapharm.2018.08.010. Epub 2018 Sep 18. Res Social Adm Pharm. 2019. PMID: 30241875

6

Deprescribing: Future directions for research.

Thompson W, Reeve E, Moriarty F, Maclure M, Turner J, Steinman MA, Conklin J, Dolovich L, McCarthy L, Farrell B. Thompson W, et al. Among authors: farrell b. Res Social Adm Pharm. 2019 Jun;15(6):801-805. doi: 10.1016/j.sapharm.2018.08.013. Epub 2018 Sep 18. Res Social Adm Pharm. 2019. PMID: 30241876 Free PMC article.

7

Deprescribing cholinesterase inhibitors and memantine in dementia: guideline summary.

Reeve E, Farrell B, Thompson W, Herrmann N, Sketris I, Magin PJ, Chenoweth L, Gorman M, Quirke L, Bethune G, Hilmer SN. Reeve E, et al. Among authors: farrell b. Med J Aust. 2019 Mar;210(4):174-179. doi: 10.5694/mja2.50015. Epub 2019 Feb 16. Med J Aust. 2019. PMID: 30771226

8

Deprescribing Guidelines: Value of an Interactive Mobile Application.

Farrell B, Grad R, Howell P, Quast T, Reeve E. Farrell B, et al. PRiMER. 2020 Sep 29;4:26. doi: 10.22454/PRiMER.2020.349237. eCollection 2020. PRiMER. 2020. PMID: 33111053 Free PMC article.

9

What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process.

Farrell B, Tsang C, Raman-Wilms L, Irving H, Conklin J, Pottie K. Farrell B, et al. PLoS One. 2015 Apr 7;10(4):e0122246. doi: 10.1371/journal.pone.0122246. eCollection 2015. PLoS One. 2015. PMID: 25849568 Free PMC article.

10

Developmental evaluation as a strategy to enhance the uptake and use of deprescribing guidelines: protocol for a multiple case study.

Conklin J, Farrell B, Ward N, McCarthy L, Irving H, Raman-Wilms L. Conklin J, et al. Among authors: farrell b. Implement Sci. 2015 Jun 18;10:91. doi: 10.1186/s13012-015-0279-0. Implement Sci. 2015. PMID: 26084798 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

345 results

Search Page